(Q48712273)

English

A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group

scientific article published in September 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

0 references

1 reference

based on heuristic

inferred from title

author name string

Miyamoto T

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Takahashi T

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Nakajima S

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Makino S

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Yamakido M

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Mano K

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Nakashima M

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Tollemar U

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Selroos O

9

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

247-256

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Inhaled glucocorticoids for asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Clinical pharmacology of corticosteroids in bronchial asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Response of patients receiving high dose beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Local versus total systemic bioavailability as a means to compare different inhaled formulations of the same substance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Identifiers

10.1046/J.1440-1843.2000.00256.X

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

release_6weypniw3rgwtjcxtg2mee6yue

1 reference

https://api.fatcat.wiki/v0/release/6weypniw3rgwtjcxtg2mee6yue

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48712273&oldid=2207559924"